Correlation Between Aequus Pharmaceuticals and Aequus Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aequus Pharmaceuticals and Aequus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aequus Pharmaceuticals and Aequus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aequus Pharmaceuticals and Aequus Pharmaceuticals, you can compare the effects of market volatilities on Aequus Pharmaceuticals and Aequus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aequus Pharmaceuticals with a short position of Aequus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aequus Pharmaceuticals and Aequus Pharmaceuticals.

Diversification Opportunities for Aequus Pharmaceuticals and Aequus Pharmaceuticals

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Aequus and Aequus is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Aequus Pharmaceuticals and Aequus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aequus Pharmaceuticals and Aequus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aequus Pharmaceuticals are associated (or correlated) with Aequus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aequus Pharmaceuticals has no effect on the direction of Aequus Pharmaceuticals i.e., Aequus Pharmaceuticals and Aequus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Aequus Pharmaceuticals and Aequus Pharmaceuticals

Assuming the 90 days horizon Aequus Pharmaceuticals is expected to generate 1.72 times more return on investment than Aequus Pharmaceuticals. However, Aequus Pharmaceuticals is 1.72 times more volatile than Aequus Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Aequus Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest  3.00  in Aequus Pharmaceuticals on September 2, 2024 and sell it today you would lose (2.00) from holding Aequus Pharmaceuticals or give up 66.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.6%
ValuesDaily Returns

Aequus Pharmaceuticals  vs.  Aequus Pharmaceuticals

 Performance 
       Timeline  
Aequus Pharmaceuticals 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aequus Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Aequus Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Aequus Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aequus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Aequus Pharmaceuticals and Aequus Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aequus Pharmaceuticals and Aequus Pharmaceuticals

The main advantage of trading using opposite Aequus Pharmaceuticals and Aequus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aequus Pharmaceuticals position performs unexpectedly, Aequus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aequus Pharmaceuticals will offset losses from the drop in Aequus Pharmaceuticals' long position.
The idea behind Aequus Pharmaceuticals and Aequus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stocks Directory
Find actively traded stocks across global markets